Scpharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$5.60(as of Jul 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Scpharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$5.60
Ticker SymbolSCPH
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees162
CountyUSA
Market Cap$308.3M
EBIDTA-66.7M
10-Day Moving Average5.05
P/E Ratio-3.31
20-Day Moving Average4.54
Forward P/E Ratio0.00
50-Day Moving Average4.05
Earnings per Share-1.92
200-Day Moving Average3.50
Profit Margin-167.99%
RSI75.26
Shares Outstanding52.8M
ATR0.30
52-Week High6.28
Volume497,056
52-Week Low1.94
Most Recent Support Level4.31
Book Value-5.1M
Most Recent Resistance Level6.28
P/B Ratio-58.63
Upper Keltner5.23
P/S Ratio7.16
Lower Keltner3.86
Debt-to-Equity Ratio5.23
Next Earnings Date08/06/2025
Cash Surplus41.2M
Next Ex-Dividend DateUnknown

scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. Its product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity and drug-device combination product candidate consisting of a prefilled syringe containing SCP-111 preloaded into a mechanical autoinjector. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Scpharmaceuticals Inc In Our Stock Scanner

As of Jul 25, 2025
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.